166 related articles for article (PubMed ID: 2655223)
1. Abrogation of alloreactive spleen cell-induced second-set skin graft rejection in mice with donor-specific bone marrow cells.
Pourshadi M; De Fazio SR; Gozzo JJ
Transplantation; 1989 May; 47(5):844-7. PubMed ID: 2655223
[TBL] [Abstract][Full Text] [Related]
2. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of secondary skin allograft rejection by veto-like cells in donor bone marrow.
Pourshadi M; De Fazio SR; Gozzo JJ
Transplantation; 1993 Aug; 56(2):385-90. PubMed ID: 8356595
[TBL] [Abstract][Full Text] [Related]
4. Induction of allograft tolerance with neonatal skin.
Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ
Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261
[TBL] [Abstract][Full Text] [Related]
5. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
6. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769
[TBL] [Abstract][Full Text] [Related]
7. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
8. Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice.
Wood ML; Gottschalk R; Monaco AP
Transplantation; 1980 Apr; 29(4):320-3. PubMed ID: 6445103
[TBL] [Abstract][Full Text] [Related]
9. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
10. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
Maki T; Gottschalk R; Wood ML; Monaco AP
J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
[TBL] [Abstract][Full Text] [Related]
11. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival in mice treated with donor bone marrow cells.
De Fazio SR; Masli S; Gozzo JJ
Transplantation; 1996 Jan; 61(1):104-10. PubMed ID: 8560547
[TBL] [Abstract][Full Text] [Related]
12. Suppressor cells in specific unresponsiveness to skin allografts in thymectomized, ALS-treated, marrow-injected mice.
Wood ML; Gottschalk R; Monaco AP
Transplantation; 1979 Nov; 28(5):387-8. PubMed ID: 160636
[TBL] [Abstract][Full Text] [Related]
13. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
Jamshidi F; De Fazio SR; Gozzo JJ
Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
[TBL] [Abstract][Full Text] [Related]
14. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
Anam K; Amare MF; Zins SR; Davis TA
Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
[TBL] [Abstract][Full Text] [Related]
15. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts.
Masli S; De Fazio SR; Gozzo JJ
Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379
[TBL] [Abstract][Full Text] [Related]
16. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
17. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells.
Monaco AP; Wood ML; Gottschalk R; Seiler FR
Transplantation; 1991 Jan; 51(1):213-8. PubMed ID: 1670970
[TBL] [Abstract][Full Text] [Related]
18. An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells.
Goldstein DR; Thomas JM; Kirklin JK; George JF
Transplantation; 2001 Sep; 72(5):954-6. PubMed ID: 11571465
[TBL] [Abstract][Full Text] [Related]
19. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow.
Markees TG; De Fazio SR; Gozzo JJ
Transplantation; 1992 Mar; 53(3):521-7. PubMed ID: 1549842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
